Can treatment success with 5% lidocaine medicated plaster be predicted in cancer pain with neuropathic components or trigeminal neuropathic pain?

An expert group of 40 pain specialists from 16 countries performed a first assessment of the value of predictors for treatment success with 5% lidocaine-medicated plaster in the management of cancer pain with neuropathic components and trigeminal neuropathic pain. Results were based on the retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Kern, Kai-Uwe, Nalamachu, Srinivas, Brasseur, Louis, Zakrzewska, Joanna M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623573/
https://www.ncbi.nlm.nih.gov/pubmed/23630431
http://dx.doi.org/10.2147/JPR.S39957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623573/
https://www.ncbi.nlm.nih.gov/pubmed/23630431
http://dx.doi.org/10.2147/JPR.S39957

Ejemplares similares